At Lambda Therapeutic Research, we bring specialized expertise in gastroenterology and hepatology to propel clinical trials encompassing a diverse spectrum of digestive and liver disorders. Our global experience spans Phase I-IV studies, covering a wide range of gastrointestinal indications. As a full-service CRO, our consistent track record in GI clinical research underlines our flexibility to adapt to the unique requirements of each trial. Collaborative planning with sponsors, coupled with our adeptness in engaging with global regulatory authorities, expedites the path to approval. We excel in effective GI trial design and defining patient eligibility criteria, enabling efficient screening and enrollment of GI patients, thus accelerating recruitment timelines.